From Spatial-temporal Multiscale Modeling to Real-world Applications in Industrial Biotechnology

Daochen Fateh^*
*Correspondence: Daochen Fateh, Department of Biology, University of British Columbia, Kelowna, Canada, Email:

Introduction

Industrial biotechnology has emerged as a critical field for sustainable production processes, offering innovative solutions for chemical manufacturing, pharmaceuticals, and biofuels. However, translating theoretical advancements into industrial applications remains a significant challenge. Spatial-temporal multiscale modeling is a powerful approach that provides insights across different scales, from molecular interactions to bioreactor performance. By integrating computational and experimental methods, this approach helps bridge the gap between fundamental research and practical implementation, accelerating industrial adoption and optimizing bioprocesses. Multiscale modeling is particularly valuable in industrial biotechnology due to the complexity of biological systems. At the microscopic level, biological reactions occur at the molecular scale, governed by enzyme kinetics, protein interactions, and metabolic pathways. These reactions scale up to cellular networks, microbial communities, and ultimately, large-scale bioprocesses. Each level introduces new variables, including spatial constraints, transport phenomena, and dynamic environmental conditions. Traditional modeling approaches often fail to capture the full complexity of these interactions, leading to inefficiencies in scaling up processes from the laboratory to industrial production.

Description

The integration of spatial-temporal modeling allows researchers to study biological systems across multiple scales, linking molecular dynamics with macroscopic system behavior. At the molecular level, computational tools such as molecular dynamics simulations provide insight into enzyme structures, reaction mechanisms, and ligand binding. These models inform metabolic pathway optimization, guiding genetic engineering strategies for improving microbial production strains. At the cellular and microbial community levels, agent-based modeling and systems biology approaches help predict microbial interactions and metabolic flux distributions. By incorporating spatial constraints, these models enable the design of optimized microbial consortia for enhanced productivity and stability. One of the critical challenges in industrial biotechnology is scaling up bioprocesses from laboratory experiments to commercial-scale production. Many promising biotechnological innovations fail to reach the market due to unforeseen issues in process scale-up. Spatial-temporal multiscale modeling addresses this challenge by providing predictive insights into transport phenomena, mass transfer limitations, and process dynamics. For example, Computational Fluid Dynamics (CFD) simulations are used to model bioreactor hydrodynamics, optimizing oxygen transfer, nutrient distribution, and shear stress conditions. These models enable the design of bioreactors that maximize productivity while minimizing operational costs [1].

Industrial biotechnology also relies on integrating real-time data with computational models for process control and optimization. Advances in sensor technology and data analytics have enabled the collection of high-resolution data on bioprocess parameters, such as pH, dissolved oxygen, and metabolite concentrations. Machine learning algorithms and Artificial Intelligence (AI)-driven models are increasingly being used to analyze these datasets, improving process predictability and control. By combining AI with multiscale modeling, researchers can develop digital twinsâ??virtual representations of bioprocesses that enable real-time optimization and predictive maintenance. Applications of spatial-temporal multiscale modeling span various industries, including biofuels, pharmaceuticals, and food biotechnology. In biofuel production, modeling is used to optimize microbial strains for enhanced lipid or ethanol production, predict fermentation dynamics, and design efficient bioreactors. In pharmaceuticals, multiscale models help in optimizing protein production in mammalian cell cultures, designing drug delivery systems, and improving bioprocess reliability. In food biotechnology, these models assist in designing microbial fermentation processes, improving flavor compound synthesis, and ensuring product consistency at an industrial scale [2,3].

Despite its potential, the adoption of spatial-temporal multiscale modeling in industrial biotechnology faces several challenges. One major limitation is the computational complexity and high resource requirements of large-scale simulations. Advances in high-performance computing and cloud-based simulation platforms are addressing these challenges, making multiscale modeling more accessible to industry practitioners. Another challenge is the integration of different modeling approaches across scales. Standardization of modeling frameworks and the development of interoperable software tools are necessary to facilitate seamless data exchange and model integration. Collaboration between academia and industry plays a crucial role in advancing the application of multiscale modeling in biotechnology. Academic research provides fundamental insights into biological mechanisms, while industrial partners contribute expertise in process engineering, regulatory compliance, and commercialization. Joint research initiatives, open-access modeling platforms, and industry-academia partnerships are essential for bridging the gap between theoretical modeling and real-world applications [4,5].

Conclusion

Regulatory considerations also impact the implementation of multiscale modeling in industrial biotechnology. Regulatory agencies increasingly recognize the value of computational models in process validation and risk assessment. The adoption of model-based approaches in regulatory frameworks can streamline approval processes for biopharmaceuticals, biosimilars, and other bioproducts. However, validation and standardization of modeling approaches remain key challenges in regulatory acceptance. The future of spatial-temporal multiscale modeling in industrial biotechnology is promising, driven by advancements in computational power, artificial intelligence, and synthetic biology. The integration of AI-driven optimization, real-time bioprocess monitoring, and automated biomanufacturing will further enhance the efficiency and scalability of industrial bioprocesses. Emerging technologies, such as organ-on-a-chip systems and synthetic microbial consortia, will benefit from multiscale modeling to accelerate research and development. As industrial biotechnology continues to evolve, the role of spatial-temporal multiscale modeling will expand, enabling more efficient, cost-effective, and sustainable bioprocesses. By addressing challenges in scale-up, process optimization, and regulatory approval, these models will play a pivotal role in translating scientific discoveries into commercial success. The continued integration of computational modeling with experimental validation and industry collaboration will be essential for realizing the full potential of industrial biotechnology in the coming decades.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Gropp, Robert E. "COVID-19 and the Bioeconomy." Biosci 70 (2020): 443-443.

Google Scholar Cross Ref Indexed at

2. Fröhling, Magnus and Michael Hiete. "Sustainability and life cycle assessment in industrial biotechnology: A review of current approaches and future needs." Sustainability and life cycle assessment in industrial biotechnology (2020): 143-203.

Google Scholar Cross Ref Indexed at

3. Kerkhoven, Eduard J., Petri-Jaan Lahtvee and Jens Nielsen. "Applications of computational modeling in metabolic engineering of yeast." FEMS Yeast Res 15 (2015): 1-13.

Google Scholar Cross Ref Indexed at

4. Schmidt, Henning and Mats Jirstrand. "Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology." Bioinform 22 (2006): 514-515.

Google Scholar Cross Ref  Indexed at

5. Seaver, Samuel MD, Filipe Liu, Qizhi Zhang and James Jeffryes, et al. "The ModelSEED Biochemistry Database for the integration of metabolic annotations and the reconstruction, comparison and analysis of metabolic models for plants, fungi and microbes." Nucleic Acids Res 49 (2021): D575-D588.

Google Scholar Cross Ref Indexed at